Analystreport

Orchard Therapeutics plc (NASDAQ: ORTX) had its price target raised by analysts at Cantor Fitzgerald from $3.00 to $15.00.

Orchard Therapeutics plc - American Depositary Shares  (ORTX) 
Last orchard therapeutics plc - american depositary shares earnings: 2/27 07:00 am Check Earnings Report